HCG introduces new-gen tomotherapyJanuary 14, 2019
HealthCare Global Enterprises Ltd (HCG) has introduced Radixact X9 – the new generation tomotherapy to treat cancer patients.
The Radixact System is being used at HCG EKO cancer centre, a partnership between HCG and EKO X-Ray & Imaging Institute, a premier institute of diagnosis from Kolkata,
The inbuilt CT scan imaging in a Radixact system allows treating bone marrow transplant patients accurately to the complete bone marrow instead of exposing all internal organs. One of the unique advantages of the system is treating children with medulloblastoma. In this case, the child can comfortably lie on his/her back and the radiation beam treats more than three times the length possible in regular machines in a single movement of the treatment couch. Radixact is both versatile and comprehensive.
Introduction of the Radixact in Kolkata is to ensure that advanced care is accessible to the patients of West Bengal and the neighboring states so that they don’t have to travel to far off locations, away from their home and close ones for cancer treatment, according to HCG officials.
HCG, which specialises in cancer care, was among the first in India to introduce the TomoH System, a fully integrated 3D conformal and image-guided intensity-modulated radiation therapy (IG-IMRT) system, and the CyberKnife Robotic Radiosurgery System, technology designed to deliver stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT).